HPV16 E6 Gene Variations in Cervical Cancer
Author Information
Author(s): Hu X, Pang T, Guo Z, Mazurenko N, Kisseljov F, Pontén J, Nistér M
Primary Institution: Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University
Hypothesis
The study investigates the sequence variations of the HPV16 E6 gene in invasive cervical squamous cell carcinoma and cancer in situ among Russian patients.
Conclusion
The study found that HPV16 E6 variants do not significantly impact the progression of invasive cervical cancer in Russian women.
Supporting Evidence
- 32 of 55 (58.2%) ICC cases were HPV 16-positive.
- 18 of 49 (36.7%) CIN cases were HPV 16-positive.
- Three groups of E6 variants were identified.
- No significant difference existed in the distribution of the different groups between ICC and CIN.
- The clinically malignant order between the groups was M > A > B in ICC.
Takeaway
The researchers looked at a virus linked to cervical cancer and found that its different versions don't seem to change how the cancer grows in women from Russia.
Methodology
The HPV16 E6 gene was amplified by PCR from fresh-frozen tissue of 104 cases of ICC and CIN and sequenced in positive cases.
Limitations
The study does not establish a significant difference in E6 variant distribution between ICC and CIN.
Participant Demographics
Russian patients with invasive cervical cancer and cervical intraepithelial neoplasia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website